Marco Antonio Ibarra-Valencia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Marco Antonio Ibarra-Valencia has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Gerardo Corzo
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, UNAM, Apartado Postal 510-3, Cuernavaca, Morelos, 61500, Mexico
3 shared publications - Gerardo Pavel Espino-Solis
Traslational Research Laboratory, Facultad de Medicina y Ciencias Biomédicas, Autonomous University of Chihuahua, Circuito Universitario s/n, Campus II, Chihuahua 31125, Mexico
2 shared publications - Astrid Tuxpan-Pérez
Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, A.P. 510-3, Cuernavaca 62250, Mexico
1 shared publication - Blanca Elisa Estrada
Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla de Baz 54090, Mexico
1 shared publication - Blanca Elisa Estrada
Translational Research Laboratory, National Laboratory of Flow Cytometry, Autonomous University of Chihuahua, Circuito Universitario, Campus II, Chihuahua 31109, Mexico
1 shared publication - Herlinda Clement
Instituto de Biotecnología—UNAM, Universidad Nacional Autónoma de México, Av. Universidad 2001, Col. Chamilpa, Cuernavaca 62210, Mexico
1 shared publication
Latest Publications
- Open Access
- 23 January 2025
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 31 (2) , 1-12
Antimicrobial and Antibiofilm Activity of Analogous Synthetic Peptides from Anoplin, Temporin, and Aurein
Introduction: The antibacterial, anti-biofilm, and hemolytic activities of five synthetic analogs of Anoplin, Temporin, and Aurein were evaluated. Methods: Five peptides, varying in length from ten to thirteen amino acids, were chemically synthesized to preserve the physicochemical characteristics inherent to the original antimicrobial peptides. These characteristics included the hydrophobic ratio, Boman index, GRAVY, stability index, and aliphatic index, with the additional objective of enhancing their antimicrobial effectiveness. Results: The most promising peptides were derived from Anoplin, particularly Anoplin_k1, which was identified as the most hydrophobic peptide with a net charge of + 2; however, it exhibited slightly increased hemolytic activity compared to the other four peptides. Anoplin_k1 demonstrated efficacy that was comparable to reference strains as well as against clinically isolated bacterial strains. The synthetic peptide Temporin ALk_k3, an analog of Temporin Alk, did not show antimicrobial activity above 100 µg/mL. Antibiofilm activity was evaluated against E. coli (K12), P. aeruginosa (PA01), and S. aureus (SH1000) reference strains. Conclusions: The peptide demonstrating the most significant antibiofilm activity was Anoplin_k1 (≤ 64 µg/mL), whereas the Aurein derivatives exhibited reduced antibiofilm activity.
- 23 January 2025
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 31 (2) , 1-12
Open AccessAntimicrobial and Antibiofilm Activity of Analogous Synthetic Peptides from Anoplin, Temporin, and Aurein
Introduction: The antibacterial, anti-biofilm, and hemolytic activities of five synthetic analogs of Anoplin, Temporin, and Aurein were evaluated. Methods: Five peptides, varying in length from ten to thirteen amino acids, were chemically synthesized to preserve the physicochemical characteristics inherent to the original antimicrobial peptides. These characteristics included the hydrophobic ratio, Boman index, GRAVY, stability index, and aliphatic index, with the additional objective of enhancing their antimicrobial effectiveness. Results: The most promising peptides were derived from Anoplin, particularly Anoplin_k1, which was identified as the most hydrophobic peptide with a net charge of + 2; however, it exhibited slightly increased hemolytic activity compared to the other four peptides. Anoplin_k1 demonstrated efficacy that was comparable to reference strains as well as against clinically isolated bacterial strains. The synthetic peptide Temporin ALk_k3, an analog of Temporin Alk, did not show antimicrobial activity above 100 µg/mL. Antibiofilm activity was evaluated against E. coli (K12), P. aeruginosa (PA01), and S. aureus (SH1000) reference strains. Conclusions: The peptide demonstrating the most significant antibiofilm activity was Anoplin_k1 (≤ 64 µg/mL), whereas the Aurein derivatives exhibited reduced antibiofilm activity.
- Open Access
- 30 April 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (5) , 607
Antimicrobial and Immunomodulatory Effects of Selected Chemokine and Antimicrobial Peptide on Cytokine Profile during Salmonella Typhimurium Infection in Mouse
The antimicrobial and immunomodulatory capacities of the peptide Css54 and the chemokine MCP-1 were tested. The first, a peptide isolated from the venom of the scorpion Centruroides suffusus suffusus was synthesized chemically. In contrast, the second is a monocyte chemoattractant expressed as a recombinant protein in our lab. It was observed in vitro that Css54 inhibited the growth of Salmonella enterica serovar Typhimurium (6.2 µg/mL). At high concentrations, it was toxic to macrophages (25 µg/mL), activated macrophage phagocytosis (1.5 µg/mL), and bound Salmonella LPS (3 µg/mL). On the other hand, the recombinant MCP-1 neither inhibited the growth of Salmonella Typhimurium nor was it toxic to macrophages (up to 25 µg/mL), nor activated macrophage phagocytosis or bound Salmonella LPS (up to 3 µg/mL). Although it was observed in vivo in mice Balb/C that both Css54 and MCP-1 did not resolve the intraperitoneal infection by S. Typhimurium, Css54 decreased the expression of IL-6 and increased IL-10, IL-12p70, and TNF-α levels; meanwhile, MCP-1 decreased the expression of IFN-γ and increased IL-12p70 and TNF-α. It was also observed that the combination of both molecules Css54 and MCP-1 increased the expression of IL-10 and TNF-α.
- 30 April 2022
- Published by MDPI AG in Antibiotics
- Vol. 11 (5) , 607
Open AccessAntimicrobial and Immunomodulatory Effects of Selected Chemokine and Antimicrobial Peptide on Cytokine Profile during Salmonella Typhimurium Infection in Mouse
The antimicrobial and immunomodulatory capacities of the peptide Css54 and the chemokine MCP-1 were tested. The first, a peptide isolated from the venom of the scorpion Centruroides suffusus suffusus was synthesized chemically. In contrast, the second is a monocyte chemoattractant expressed as a recombinant protein in our lab. It was observed in vitro that Css54 inhibited the growth of Salmonella enterica serovar Typhimurium (6.2 µg/mL). At high concentrations, it was toxic to macrophages (25 µg/mL), activated macrophage phagocytosis (1.5 µg/mL), and bound Salmonella LPS (3 µg/mL). On the other hand, the recombinant MCP-1 neither inhibited the growth of Salmonella Typhimurium nor was it toxic to macrophages (up to 25 µg/mL), nor activated macrophage phagocytosis or bound Salmonella LPS (up to 3 µg/mL). Although it was observed in vivo in mice Balb/C that both Css54 and MCP-1 did not resolve the intraperitoneal infection by S. Typhimurium, Css54 decreased the expression of IL-6 and increased IL-10, IL-12p70, and TNF-α levels; meanwhile, MCP-1 decreased the expression of IFN-γ and increased IL-12p70 and TNF-α. It was also observed that the combination of both molecules Css54 and MCP-1 increased the expression of IL-10 and TNF-α.
- Open Access
Immunomodulatory Responses of Two Synthetic Peptides against Salmonella Typhimurium Infection
In vitro assays of phagocytic activity showed that the peptide Pin2[G] stimulates phagocytosis in BMDM cells from 0.15 to 1.25 μg/mL, and in RAW 264.7 cells at 0.31 μg/mL. In the same way, the peptide FA1 induced phagocytosis in BMDM cells from 1.17 to 4.69 μg/mL and in RAW 264.7 cells at 150 μg/mL. Cytokine profiles of uninfected RAW 264.7 showed that Pin2[G] increased liberation TNF (from 1.25 to 10 μg/mL) and MCP-1 (10 μg/mL), and FA1 also increased the release of TNF (from 18.75 to 75 μg/mL) but did not increase the liberation of MCP-1. In RAW 264.7 macrophages infected with Salmonella enterica serovar Typhimurium, the expression of TNF increases with Pin2[G] (1.25–10 μg/mL) or FA1 (18.75–75 μg/mL). In these cells, FA1 also increases the expression of IL-12p70, IL-10 and IFN-γ when applied at concentrations of 37.5, 75 and 150 μg/mL, respectively. On the other hand, stimulation with 1.25 and 10 μg/mL of Pin2[G] promotes the expression of MCP-1 and IL-12p70, respectively. Finally, peptides treatment did not resolve murine gastric infection, but improves their physical condition. Cytokine profiles showed that FA1 reduces IFN-γ and MCP-1 but increases IL-10, while Pin2[G] reduces IFN-γ but increases the liberation of IL-6 and IL-12p70. This data suggests a promising activity of FA1 and Pin2[G] as immunomodulators of gastric infections in S. Typhimurium.
Open AccessImmunomodulatory Responses of Two Synthetic Peptides against Salmonella Typhimurium Infection
In vitro assays of phagocytic activity showed that the peptide Pin2[G] stimulates phagocytosis in BMDM cells from 0.15 to 1.25 μg/mL, and in RAW 264.7 cells at 0.31 μg/mL. In the same way, the peptide FA1 induced phagocytosis in BMDM cells from 1.17 to 4.69 μg/mL and in RAW 264.7 cells at 150 μg/mL. Cytokine profiles of uninfected RAW 264.7 showed that Pin2[G] increased liberation TNF (from 1.25 to 10 μg/mL) and MCP-1 (10 μg/mL), and FA1 also increased the release of TNF (from 18.75 to 75 μg/mL) but did not increase the liberation of MCP-1. In RAW 264.7 macrophages infected with Salmonella enterica serovar Typhimurium, the expression of TNF increases with Pin2[G] (1.25–10 μg/mL) or FA1 (18.75–75 μg/mL). In these cells, FA1 also increases the expression of IL-12p70, IL-10 and IFN-γ when applied at concentrations of 37.5, 75 and 150 μg/mL, respectively. On the other hand, stimulation with 1.25 and 10 μg/mL of Pin2[G] promotes the expression of MCP-1 and IL-12p70, respectively. Finally, peptides treatment did not resolve murine gastric infection, but improves their physical condition. Cytokine profiles showed that FA1 reduces IFN-γ and MCP-1 but increases IL-10, while Pin2[G] reduces IFN-γ but increases the liberation of IL-6 and IL-12p70. This data suggests a promising activity of FA1 and Pin2[G] as immunomodulators of gastric infections in S. Typhimurium.